Loading organizations...

§ Private Profile · San Mateo, CA, USA
Neosensory is a technology company.
Neosensory has raised $10.0M across 1 funding round.
Key people at Neosensory.
Neosensory has raised $10.0M in total across 1 funding round.
Neosensory develops innovative vibration-based wearable devices designed to enhance sensory perception. Their core product, a wristband, translates ambient sounds into distinct vibratory patterns felt on the wearer's skin. This bimodal neuromodulation approach offers solutions for improved speech comprehension and effective tinnitus management by providing the brain with novel auditory information through touch.
The company was co-founded in 2014 by neuroscientists David Eagleman and Scott Novich. Dr. Eagleman, hailing from Stanford, brought expertise in neuroplasticity and sensory substitution. Their foundational insight centered on leveraging the brain's inherent ability to adapt and interpret new forms of sensory input, establishing a non-invasive brain-machine interface for broader application.
Neosensory's products primarily serve individuals experiencing hearing challenges and those seeking relief from tinnitus, including veterans. The company aims to expand human sensory capabilities and improve quality of life by providing alternative pathways for perceiving the world. Their vision is to redefine how individuals experience and interact with their auditory environment.
Neosensory has raised $10.0M in total across 1 funding round.
Neosensory's investors include David Kim, MD, Juan Enriquez, Endeavor Venture Funds, New Age Ventures, Next Coast Ventures, Redpoint Ventures, S3 Ventures, Tensility Venture Partners, True Wealth Ventures, Tao Capital, True Ventures.
Neosensory has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in May 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 1, 2018 | $10M Series A | David Kim, MD, Juan Enriquez | Endeavor Venture Funds, NEW AGE Ventures, Next Coast Ventures, Redpoint Ventures, S3 Ventures, Tensility Venture Partners, True Wealth Ventures, TAO Capital, True Ventures | Announced |
Neosensory is a neuroscience-driven technology company that develops wearable devices designed to create new sensory experiences by converting data streams—such as sound—into patterns of vibrations on the skin. Its flagship product, the Buzz wristband, serves primarily people with hearing loss or tinnitus by providing an alternative sensory channel to perceive sounds through haptic feedback. This technology addresses the limitations and costs of traditional hearing aids and cochlear implants, enabling users to "listen" via their skin. Neosensory has demonstrated strong growth momentum, recently securing $10 million in Series A funding to accelerate product release and global expansion[1][3][6].
Neosensory was co-founded by neuroscientists David Eagleman and Scott Novich, who began their research in 2013 while Novich was a PhD student and Eagleman a professor. Their initial idea was to create a general sensory substitution device, the VEST, which gained significant attention after Eagleman’s TED talk on creating new human senses. Supported by True Ventures, the technology was spun out of the lab into an independent company in 2015. Early pivotal moments include the development of the wristband form factor, which miniaturized the technology for consumer use, and the successful demonstration that users with severe hearing loss could interpret sound through skin vibrations[1][2][6].
Neosensory rides the wave of growing interest in brain-machine interfaces and sensory augmentation technologies. The timing is favorable due to advances in wearable tech, neuroscience, and haptic feedback, combined with increasing demand for accessible hearing solutions. Market forces such as the rising prevalence of hearing loss and the limitations of existing devices create a strong need for innovative alternatives. Neosensory’s work influences the broader ecosystem by pioneering non-invasive sensory substitution, potentially expanding human perception and inspiring further research and product development in neurotechnology and assistive devices[1][2][6].
Looking ahead, Neosensory is poised to expand its product line and refine its algorithms to address more nuanced auditory challenges, such as high-frequency hearing loss and tinnitus treatment through bimodal stimulation. Trends in personalized healthcare, wearable neurotechnology, and sensory augmentation will shape its journey. As the company scales globally, its influence may extend beyond hearing assistance to broader applications of sensory substitution, potentially redefining how humans interact with data and their environment. Neosensory’s vision of creating new senses aligns with a future where technology fundamentally expands human perception[1][6].
Key people at Neosensory.